PROS1 and glioblastoma: Although the study has the previously mentioned limitations, it still shows that analysis of EV surface protein signatures may provide valuable insights into the molecular and clinical diversity of GBM, highlighting potential markers for prognosis, therapeutic response, and immune modulation.